Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Syed Sahajada Mahafujul Alam

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Functional & Integrative Genomics|January 11, 2023
Evaluating the transmission feasibility of SARS-CoV-2 Omicron (B.1.1.529) variant to 143 mammalian hosts: insights from S protein RBD and host ACE2 interaction studiesArijit Samanta, Syed Sahajada Mahafujul Alam, Safdar Ali, et al.
International Journal of Biological Macromolecules|January 15, 2026
Rational design of peptide-based programmed cell death 1 immune checkpoint inhibitors using advanced integrated computational approachArijit Samanta, Syed Sahajada Mahafujul Alam, Safdar Ali, et al.
EXCLI Journal|June 2, 2022
Analyzing the interaction of human ACE2 and RBD of spike protein of SARS-CoV-2 in perspective of Omicron variantArijit Samanta, Syed Sahajada Mahafujul Alam, Safdar Ali, et al.
Biochemical and Biophysical Research Communications|September 22, 2025
Structural insights into the impacts of non-synonymous single nucleotide polymorphisms in CD274 gene on the PD-1/PD-L1 interaction: An in silico approachSyed Sahajada Mahafujul Alam, Arijit Samanta, Safdar Ali, et al.
Pharmacological Reports : PR|July 13, 2023
Tanshinone IIA targeting cell signaling pathways: a plausible paradigm for cancer therapySyed Sahajada Mahafujul Alam, Arijit Samanta, Faizan Uddin, et al.
International Journal of Molecular Sciences|April 13, 2023
Curcumin and Plumbagin Synergistically Target the PI3K/Akt/mTOR Pathway: A Prospective Role in Cancer TreatmentIftikhar Ahmad, Mehboob Hoque, Syed Sahajada Mahafujul Alam, et al.
Scientific Reports|April 11, 2025
Immunoinformatics based designing of a multi-epitope cancer vaccine targeting programmed cell death ligand 1Syed Sahajada Mahafujul Alam, Showkat Ahmad Mir, Arijit Samanta, et al.
Neuroscience and Biobehavioral Reviews|November 26, 2022
Nanomedicine-based immunotherapy for Alzheimer's diseaseMehboob Hoque, Arijit Samanta, Syed Sahajada Mahafujul Alam, et al.
Journal of Cellular Biochemistry|January 12, 2024
Nonsynonymous mutations in VEGF receptor binding domain alter the efficacy of bevacizumab treatmentAshif Ahamed, Arijit Samanta, Syed Sahajada Mahafujul Alam, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|April 4, 2022
Identification of Potential Poly (ADP-Ribose) Polymerase-1 Inhibitors Derived from <i>Rauwolfia serpentina</i>: Possible Implication in Cancer TherapyAdel M Abuzenadah, Fatin Al-Sayes, Syed Sahajada Mahafujul Alam, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Functional & Integrative Genomics|January 11, 2023
Evaluating the transmission feasibility of SARS-CoV-2 Omicron (B.1.1.529) variant to 143 mammalian hosts: insights from S protein RBD and host ACE2 interaction studiesArijit Samanta, Syed Sahajada Mahafujul Alam, Safdar Ali, et al.
International Journal of Biological Macromolecules|January 15, 2026
Rational design of peptide-based programmed cell death 1 immune checkpoint inhibitors using advanced integrated computational approachArijit Samanta, Syed Sahajada Mahafujul Alam, Safdar Ali, et al.
EXCLI Journal|June 2, 2022
Analyzing the interaction of human ACE2 and RBD of spike protein of SARS-CoV-2 in perspective of Omicron variantArijit Samanta, Syed Sahajada Mahafujul Alam, Safdar Ali, et al.
Biochemical and Biophysical Research Communications|September 22, 2025
Structural insights into the impacts of non-synonymous single nucleotide polymorphisms in CD274 gene on the PD-1/PD-L1 interaction: An in silico approachSyed Sahajada Mahafujul Alam, Arijit Samanta, Safdar Ali, et al.
Pharmacological Reports : PR|July 13, 2023
Tanshinone IIA targeting cell signaling pathways: a plausible paradigm for cancer therapySyed Sahajada Mahafujul Alam, Arijit Samanta, Faizan Uddin, et al.
International Journal of Molecular Sciences|April 13, 2023
Curcumin and Plumbagin Synergistically Target the PI3K/Akt/mTOR Pathway: A Prospective Role in Cancer TreatmentIftikhar Ahmad, Mehboob Hoque, Syed Sahajada Mahafujul Alam, et al.
Scientific Reports|April 11, 2025
Immunoinformatics based designing of a multi-epitope cancer vaccine targeting programmed cell death ligand 1Syed Sahajada Mahafujul Alam, Showkat Ahmad Mir, Arijit Samanta, et al.
Neuroscience and Biobehavioral Reviews|November 26, 2022
Nanomedicine-based immunotherapy for Alzheimer's diseaseMehboob Hoque, Arijit Samanta, Syed Sahajada Mahafujul Alam, et al.
Journal of Cellular Biochemistry|January 12, 2024
Nonsynonymous mutations in VEGF receptor binding domain alter the efficacy of bevacizumab treatmentAshif Ahamed, Arijit Samanta, Syed Sahajada Mahafujul Alam, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|April 4, 2022
Identification of Potential Poly (ADP-Ribose) Polymerase-1 Inhibitors Derived from <i>Rauwolfia serpentina</i>: Possible Implication in Cancer TherapyAdel M Abuzenadah, Fatin Al-Sayes, Syed Sahajada Mahafujul Alam, et al.
Pageof 2